ZORYANA TUZ: Open Payments
NPI 1982055158 · NEPTUNE CITY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,448 in 31 payments from 13 companies in 2025. Trend: 2023 $852 · 2024 $1,413 · 2025 $1,448
Food & beverage: $1,448
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $282 |
| Alnylam Pharmaceuticals Inc. | 3 | $271 |
| Novo Nordisk Inc | 6 | $259 |
| E.R. Squibb & Sons, L.L.C. | 7 | $214 |
| AstraZeneca Pharmaceuticals LP | 1 | $124 |
| Actelion Pharmaceuticals US, Inc. | 1 | $87 |
| Boston Scientific Corporation | 2 | $60 |
| ABIOMED | 1 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
| Lilly USA, LLC | 1 | $20 |
Products named: Repatha, AMVUTTRA, Wegovy, CAMZYOS, WAINUA, Ozempic, UPTRAVI, ELIQUIS.
Industry payments across NJ — which companies pay providers there.
